The private equity landscape in ophthalmology is shifting fast—and knowing where it’s headed matters. Join Matt Jensen for an insight-rich conversation with Chris Moore, CEO of Vision Innovation Partners, as they share firsthand insights into how PE groups are approaching deals today, what factors are driving valuations, and how the landscape is shaping up as we move toward 2026.
Join to the conversation: https://events.zoom.us/ev/AnEFuA4ItKEC8TZb-qAm-JlOMPZCJCIFmVa6RPFOX4hsadSnEEuM~Au5vA1AUBnvUTHw0CoPDtDUwz0wb5BQJ378FvBPD5NBrqmp-k4c5e2GOLA